-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Quest Diagnostics, Raises Price Target to $182

Benzinga·12/13/2024 15:53:47
Listen to the news
B of A Securities analyst Derik De Bruin maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $179 to $182.